Inside a $175M Deal: Tim McLoughlin & Joshua Hayes Live From RDU Startup Week
What's Shaping the Capital Raising Environment?
Raising a Down Round and How to Be Prepared
Developing an AI Policy for Your Startup
Due Diligence in AI: Thinking like your biggest critic
JONES DAY TALKS®: A Trip to the Dark Side – Venture Capital Down Rounds and Recaps
PODCAST: Williams Mullen's Raising Capital 101: A Securities Podcast - Why Raise Capital?
PODCAST: Williams Mullen's Raising Capital 101: A Securities Podcast - The Aspects of Raising Capital from Start-Ups to More Established Companies
Embracing Change & Community: The Keys To Startup Success With Chris Heivly
The Best of Founder Shares: Highlights Wisdom of Season's Guests
A Conversation with Janade du Plessis of Launch Africa Ventures: Balancing Sustainable Development with ROI
The Force is Strong with this One – Success and Paying it Forward with Co-Founder of ChannelAdvisor and Spiffy Scot Wingo
Hunting Outsized Returns with Jason Caplain of Bull City Venture Partners
Through the Lens: From serial entrepreneur to neutral who gets deals done - Focus on Daniel Garrie
A View From the Starting Line – A Conversation with Teenpreneur Tierney Schmidt
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 159: Bob Quinn, Executive Director, and Adrianne Grimes, Director of Marketing and Comms, SCRA
From Accidental Entrepreneur to a $2.5M raise, with Cycle Labs' Josh Owen
The One Reason Startups Fail, with VentureSouth's Charlie Banks
When Two is Better Than One: Murphy’s Naturals and The Loading Dock Story with Philip Freeman
Huddling with Hutch adVENTURES: Behind the scenes with an early-stage venture capital firm
Wilson Sonsini’s 2nd Annual Biotech Summit will address topics of critical importance to biotech and biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI...more
On promising workflow automation trends: “The blend between services and software is increasingly merging, as the focus moves toward delivering the ‘work’ or ‘outcome’ to a customer versus just the ‘software to support doing...more
If you’re raising early-stage capital, the outlook appears strong, but for late-stage companies, the bar is higher than ever. In partnership with Aumni, a J.P. Morgan company, we’re pleased to share the Q2 2025 edition of the...more
At New York Tech Week 2025, cybersecurity took the spotlight. Fenwick partner Jon Lenzner sat down with Bryan Vorndran—former assistant director of the FBI’s Cyber Division—to unpack what early-stage companies, investors, and...more
As we head into the second half of 2025, the prospects for innovation in robotics and artificial intelligence (AI) seem limitless. It is difficult to find an industry that hasn’t touted the potential for robotics and AI to...more
From lab to commercialization: Navigate the evolving risks of life science companies - Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding...more
As we kick off 2025, it's worth reflecting on the forces that shaped digital health in 2024. From early-stage innovation capturing investor attention to mega funds like a16z and General Catalyst driving dealmaking, the year...more
When developing an internal company artificial intelligence policy, there are three main things that a policy should do. One, it should explain to employees what types of tools they can use and what types of accounts they...more
01 A conversation with Evercore on the market outlook 02 Will there be an alternative path to public? 03 What’s ahead for tech and life sciences IPOs? 04 The Download Quiz: Venture Capital Trends / 01A CONVERSATION WITH...more
This update is part of our EU AI Act Series. Learn more about the EU AI Act here. Like other companies, startups that develop, use or commercialize AI systems or general-purpose AI models (GPAIMs) that people in the EU use...more
Founders and folks that are really pushing the envelope in this space need to be careful with how they describe their tools when it comes to due diligence. We're working from an environment where most people are just focused...more
Wilson Sonsini’s inaugural Biotech Summit will address topics of critical importance to Biotech and Biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI...more
In the rapidly evolving landscape of AI, the valuation and viability of AI companies are extensively tied to their intellectual property assets. For AI companies, safeguarding these assets is not just about legal...more
Wilson Sonsini’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies, including early and late-stage venture financing, partnering...more
As is the case with most emerging technologies, developments in artificial intelligence (AI) are quickly outpacing regulations, and with this comes a variety of important legal considerations. While there has been a push for...more
Welcome to the March edition of Blakes upRound, a regular publication from the Blakes Emerging Companies & Venture Capital (EC&VC) group that highlights legal developments relevant to venture investors and emerging companies...more
Introduction - Welcome to the second issue of The Scramble, presented by Wilson Sonsini’s Electronic Gaming Group. Wilson Sonsini has advised hundreds of clients throughout the gaming sector. The Scramble is an annual...more
Food Venture Financing Trends - Amara, an organic baby food brand, announced that it raised $20 million in its Series B financing. Liquid Death, a fast-growing non-alcoholic brand, announced that it has raised $67...more
2023 was a pivotal year for the emerging companies, creating new categories of winners and losers across the board. Emerging companies incorporating artificial intelligence or that have clear line of sight to positive cash...more
In this latest issue of The Entrepreneurs Report, we've compiled a range of data on venture financing transactions and convertible note financings in which the firm was involved in Q3 2023, with the objective of identifying...more
Morrison Foerster is pleased to share with our clients and friends the results of our 2023 Tech M&A Survey, published in conjunction with Mergermarket. Mergermarket surveyed 300 dealmakers from around the world in order to...more
Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the...more